Eight lots of Medisca's L-citrulline supplements for treatment of children with genetic conditions were voluntarily recalled after testing indicated the absence of the drug itself, the FDA announced Saturday. Without the drug, the supplements "represent a potential health hazard," the company said in a statement.

Full Story:

Related Summaries